Literature DB >> 27398134

Inflammatory bowel disease related innate immunity and adaptive immunity.

Yuan Huang1, Zhonge Chen2.   

Abstract

Inflammatory bowel disease (IBD) is a chronic nonspecific intestinal inflammatory disease, including ulcerative colitis (UC) and Crohn's disease (CD). Its pathogenesis remains not yet clear. Current researchers believe that after environmental factors act on individuals with genetic susceptibility, an abnormal intestinal immune response is launched under stimulation of intestinal flora. However, previous studies only focused on adaptive immunity in the pathogenesis of IBD. Currently, roles of innate immune response in the pathogenesis of intestinal inflammation have also drawn much attention. In this study, IBD related innate immunity and adaptive immunity were explained, especially the immune mechanisms in the pathogenesis of IBD.

Entities:  

Keywords:  Inflammatory bowel disease; adaptive immunity; innate immunity; pathogenesis

Year:  2016        PMID: 27398134      PMCID: PMC4931145     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  44 in total

Review 1.  Role of Rho kinase signal pathway in inflammatory bowel disease.

Authors:  Yuan Huang; Shiyu Xiao; Quanhang Jiang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.

Authors:  Ivaylo I Ivanov; Brent S McKenzie; Liang Zhou; Carlos E Tadokoro; Alice Lepelley; Juan J Lafaille; Daniel J Cua; Dan R Littman
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

3.  Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes.

Authors:  Monika Baj-Krzyworzeka; Rafał Szatanek; Kazimierz Weglarczyk; Jarosław Baran; Barbara Urbanowicz; Piotr Brański; Mariusz Z Ratajczak; Marek Zembala
Journal:  Cancer Immunol Immunother       Date:  2005-11-09       Impact factor: 6.968

Review 4.  Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases.

Authors:  Warren Strober; Ivan J Fuss
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

Review 5.  Human defensins in Crohn's disease.

Authors:  Jan Wehkamp; Klaus Fellermann; Eduard F Stange
Journal:  Chem Immunol Allergy       Date:  2005

Review 6.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

7.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease.

Authors:  Lauren A Zenewicz; George D Yancopoulos; David M Valenzuela; Andrew J Murphy; Sean Stevens; Richard A Flavell
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

8.  Increased expression of antimicrobial peptides and lysozyme in colonic epithelial cells of patients with ulcerative colitis.

Authors:  A Fahlgren; S Hammarström; A Danielsson; M-L Hammarström
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

Review 9.  Regulatory T cells in inflammatory bowel disease.

Authors:  Elisa K Boden; Scott B Snapper
Journal:  Curr Opin Gastroenterol       Date:  2008-11       Impact factor: 3.287

Review 10.  How intestinal epithelial cells tolerise dendritic cells and its relevance to inflammatory bowel disease.

Authors:  M Shale; S Ghosh
Journal:  Gut       Date:  2009-09       Impact factor: 23.059

View more
  40 in total

Review 1.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

2.  Downregulation of iNOS and elevation of cAMP mediate the anti-inflammatory effect of glabridin in rats with ulcerative colitis.

Authors:  Nahla E El-Ashmawy; Naglaa F Khedr; Hoda A El-Bahrawy; Samar A El-Adawy
Journal:  Inflammopharmacology       Date:  2017-07-13       Impact factor: 4.473

Review 3.  Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease.

Authors:  Jie Wang; Idan Goren; Bo Yang; Sinan Lin; Jiannan Li; Michael Elias; Claudio Fiocchi; Florian Rieder
Journal:  Aliment Pharmacol Ther       Date:  2021-12-21       Impact factor: 8.171

4.  Therapeutic efficacy of rifaximin loaded tamarind gum polysaccharide nanoparticles in TNBS induced IBD model Wistar rats.

Authors:  Maria John Newton Amaldoss; Imtiyaz Ahmed Najar; Jatinder Kumar; Archana Sharma
Journal:  Rep Pract Oncol Radiother       Date:  2021-09-30

Review 5.  Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.

Authors:  Wei Jia; Guoxiang Xie; Weiping Jia
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-10-11       Impact factor: 46.802

6.  Temporal induction of intestinal epithelial hypoxia-inducible factor-2α is sufficient to drive colitis.

Authors:  Sumeet Solanki; Samantha N Devenport; Sadeesh K Ramakrishnan; Yatrik M Shah
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-06-26       Impact factor: 4.052

7.  Effects of dihydroartemisinin, a metabolite of artemisinin, on colon cancer chemoprevention and adaptive immune regulation.

Authors:  Chong-Zhi Wang; Chunping Wan; Yun Luo; Chun-Feng Zhang; Qi-Hui Zhang; Lina Chen; Zhi Liu; Daniel H Wang; Mallory Lager; Cang-Hai Li; Ting-Liang Jiang; Lifei Hou; Chun-Su Yuan
Journal:  Mol Biol Rep       Date:  2022-01-18       Impact factor: 2.316

8.  Ginseng berry concentrate prevents colon cancer via cell cycle, apoptosis regulation, and inflammation-linked Th17 cell differentiation.

Authors:  C-Z Wang; C Wan; Y Luo; C-F Zhang; Q-H Zhang; L Chen; C W Park; S H Kim; Z Liu; M Lager; M Xu; L Hou; C-S Yuan
Journal:  J Physiol Pharmacol       Date:  2021-08-06       Impact factor: 3.011

9.  Intestinal Transcriptome Analysis Reveals Enrichment of Genes Associated with Immune and Lipid Mechanisms, Favoring Soybean Meal Tolerance in High-Growth Zebrafish (Danio Rerio).

Authors:  Luis Valenzuela; Sebastian Pacheco; Gonzalo Rincón; Leonardo Pavez; Natalia Lam; Adrián J Hernández; Patricio Dantagnan; Felipe González; Felipe Jilberto; M Cristina Ravanal; Cecilia Ramos; Héctor Garcia; Cristian Araneda; Pilar E Ulloa
Journal:  Genes (Basel)       Date:  2021-05-08       Impact factor: 4.096

Review 10.  Bile Acids Activated Receptors in Inflammatory Bowel Disease.

Authors:  Michele Biagioli; Silvia Marchianò; Adriana Carino; Cristina Di Giorgio; Luca Santucci; Eleonora Distrutti; Stefano Fiorucci
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.